FDA Advisors Recommend AstraZeneca And Sanofi Antibody For P

(CTN News) - Among the top causes of newborn hospitalization is an (RSV) respiratory syncytial virus, and a panel of independent advisors to the FDA

Related Keywords

United States , San Diego , California , Canada , United Kingdom , American , Melissa Baylor , Nimish Patel , Manish Shroff , University Of California , Astrazeneca , Pfizer , First Medical Intervention , Future Considerations ,